Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Patients who were counseled on heart medications and lifestyle modifications by specially trained nurses were 30% less likely to experience ...
The rate of cardiovascular death, nonfatal heart attack, or nonfatal stroke was 30% lower among patients receiving nurse-led ...
The following is a summary of “Effect of sarcopenia on prognosis in patients with mild acute ischemic stroke: a prospective ...
2d
Luton Today on MSNStroke patients to receive quicker care through video assessmentsFrom Monday 31 March, the stroke team at the Luton and Dunstable University Hospital (L&D) will be working with colleagues at ...
Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Aspiration pneumonia in post-stroke patients showed significantly increased 90-day mortality, longer hospital stays, and more ...
HealthDay News — In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the Annals of Internal Medicine, recommendations are presented for the ...
Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results